These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 27646893)
1. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma]. Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893 [TBL] [Abstract][Full Text] [Related]
2. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Machado I; Navarro S; Picci P; Llombart-Bosch A Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835 [TBL] [Abstract][Full Text] [Related]
3. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas. Davis JL; Horvai AE Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma. Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430 [TBL] [Abstract][Full Text] [Related]
5. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Conner JR; Hornick JL Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429 [TBL] [Abstract][Full Text] [Related]
6. Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Wojcik JB; Bellizzi AM; Dal Cin P; Bredella MA; Fletcher CD; Hornicek FJ; Deshpande V; Hornick JL; Nielsen GP Am J Surg Pathol; 2014 Nov; 38(11):1538-44. PubMed ID: 24921641 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112 [TBL] [Abstract][Full Text] [Related]
8. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases. Sangoi AR; Kshirsagar M; Horvai AE; Roma AA Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605 [TBL] [Abstract][Full Text] [Related]
9. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice. Urist MR; Grant TT; Lindholm TS; Mirra JM; Hirano H; Finerman GA J Bone Joint Surg Am; 1979 Dec; 61(8):1207-16. PubMed ID: 229105 [TBL] [Abstract][Full Text] [Related]
17. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics. Jiang L; Liu J; Wei Q; Wang Y Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814 [TBL] [Abstract][Full Text] [Related]
18. h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. Watanabe K; Tajino T; Sekiguchi M; Suzuki T Am J Clin Pathol; 2000 May; 113(5):663-8. PubMed ID: 10800398 [TBL] [Abstract][Full Text] [Related]
19. SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma. Ordóñez NG Adv Anat Pathol; 2014 Jan; 21(1):63-7. PubMed ID: 24316906 [TBL] [Abstract][Full Text] [Related]
20. Sarcomas metastatic to the ovary: a report of 21 cases. Young RH; Scully RE Int J Gynecol Pathol; 1990; 9(3):231-52. PubMed ID: 2373588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]